FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3129477788> ?p ?o ?g. }

• W3129477788 abstract "Abstract Background Pseudomonas aeruginosa has recently shown to be one of the most important strains of bacteria and alert pathogens in Europe among Intensive Care Unit patients that provide serious therapeutic problems because of its multidrug resistance. Methods The purpose of this microbiological study was data analysis of device associated- healthcare associated infections (DA-HAIs) in an ICU in terms of the incidents of P.aeruginosa strain infections and its susceptibility within an 8.5-year observation. Results Among 919 isolated strains responsible for 799 DA-HAIs (17,62 ± 1,98/1000 patient-days) in 4010 ICU patients P.aeruginosa was the pathogen in 108/799 (13.52%) cases. Incidence rate (density) of: VAP/1000 MV- days, UTI /1000 UC- days and CLA-BSI/1000 CL- days were 11,15 ± 2.5, 6.82 ± 0.81, 2.35 ± 1.54.respectivelly. P.aeruginosa was the pathogen most frequently responsible for VAP 69/108 (63.88%). Mean frequency of VAP, UTI and CLA-BSI with P.aeruginosa etiology was 69/493 (14.28%), 32/299 (11.1%) and 7/127 (5.77%) respectively. The mean density of P.aeruginosa infection amounted to 2.43/1000 patient-days. The decrease was observed in the total number of DA-HAIs caused by the P.aeruginosa from 15.75% and 3.23/1000 patient-days in 2011 to 5.0% and 1.17/1000 in 2016 ( p = 0.0104, p = 0.0348). Starting from 2016 to 2019 incidence and density of P.aeruginosa DA-HAIs increased to 12.33% and 2.63/1000 ( p = 0.1388, p = 0.0818). P.aeruginosa was susceptible to ceftazidime, cefepime, amikacin, meropenem, ciprofloxacin, colistin, in 55.55, 58.33, 70.37, 53.73, 50, and 100% respectively. MDR characterised it in 40% in 2011 and 66.7% in 2019, ( p = 0.177). Conclusions The study revealed a changeable prevalence of P. aeruginosa strain infections; however their frequency was never highest in our ICU patients as it presented in the last years in Europe. The study showed a significant decrease in 2016 and increase in 2019, a nearly 3-fold increase of P.aeruginosa infections among Gram-negative strain infections, and a 2-fold increase of the P.aeruginosa DA-HAIs frequency between 2016 and 2019 as well as an increased resistance. Microbiological analysis of DA-HAIs in each hospital should be a standard method used in hospital infection control and antibiotic policy. In the case of P.aeruginosa, in order to minimize transmission, preventive infection methods should be assessed mainly in case of VAP." @default.
• W3129477788 created "2021-03-01" @default.
• W3129477788 creator A5033021717 @default.
• W3129477788 creator A5049947642 @default.
• W3129477788 creator A5057447508 @default.
• W3129477788 creator A5083338687 @default.
• W3129477788 date "2021-02-16" @default.
• W3129477788 modified "2023-10-14" @default.
• W3129477788 title "Pseudomonas aeruginosa device associated – healthcare associated infections and its multidrug resistance at intensive care unit of University Hospital: polish, 8.5-year, prospective, single-centre study" @default.
• W3129477788 cites W1858431697 @default.
• W3129477788 cites W2034200083 @default.
• W3129477788 cites W2054938569 @default.
• W3129477788 cites W2056376214 @default.
• W3129477788 cites W2142343447 @default.
• W3129477788 cites W2156990746 @default.
• W3129477788 cites W2159078156 @default.
• W3129477788 cites W2165158988 @default.
• W3129477788 cites W2273180267 @default.
• W3129477788 cites W2305550777 @default.
• W3129477788 cites W2782615663 @default.
• W3129477788 cites W2801221792 @default.
• W3129477788 cites W2807161463 @default.
• W3129477788 cites W2817614309 @default.
• W3129477788 cites W2901929987 @default.
• W3129477788 cites W2935965351 @default.
• W3129477788 cites W3012868903 @default.
• W3129477788 cites W4230357700 @default.
• W3129477788 cites W4236679102 @default.
• W3129477788 cites W4294990605 @default.
• W3129477788 cites W2982395064 @default.
• W3129477788 doi "https://doi.org/10.1186/s12879-021-05883-5" @default.
• W3129477788 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7885137" @default.
• W3129477788 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33593280" @default.
• W3129477788 hasPublicationYear "2021" @default.
• W3129477788 type Work @default.
• W3129477788 sameAs 3129477788 @default.
• W3129477788 citedByCount "22" @default.
• W3129477788 countsByYear W31294777882021 @default.
• W3129477788 countsByYear W31294777882022 @default.
• W3129477788 countsByYear W31294777882023 @default.
• W3129477788 crossrefType "journal-article" @default.
• W3129477788 hasAuthorship W3129477788A5033021717 @default.
• W3129477788 hasAuthorship W3129477788A5049947642 @default.
• W3129477788 hasAuthorship W3129477788A5057447508 @default.
• W3129477788 hasAuthorship W3129477788A5083338687 @default.
• W3129477788 hasBestOaLocation W31294777881 @default.
• W3129477788 hasConcept C120665830 @default.
• W3129477788 hasConcept C121332964 @default.
• W3129477788 hasConcept C126322002 @default.
• W3129477788 hasConcept C133936738 @default.
• W3129477788 hasConcept C177713679 @default.
• W3129477788 hasConcept C188816634 @default.
• W3129477788 hasConcept C190139176 @default.
• W3129477788 hasConcept C203014093 @default.
• W3129477788 hasConcept C2776376669 @default.
• W3129477788 hasConcept C2777637488 @default.
• W3129477788 hasConcept C2987404301 @default.
• W3129477788 hasConcept C501593827 @default.
• W3129477788 hasConcept C523546767 @default.
• W3129477788 hasConcept C54355233 @default.
• W3129477788 hasConcept C61511704 @default.
• W3129477788 hasConcept C71924100 @default.
• W3129477788 hasConcept C86803240 @default.
• W3129477788 hasConcept C89423630 @default.
• W3129477788 hasConcept C94665300 @default.
• W3129477788 hasConceptScore W3129477788C120665830 @default.
• W3129477788 hasConceptScore W3129477788C121332964 @default.
• W3129477788 hasConceptScore W3129477788C126322002 @default.
• W3129477788 hasConceptScore W3129477788C133936738 @default.
• W3129477788 hasConceptScore W3129477788C177713679 @default.
• W3129477788 hasConceptScore W3129477788C188816634 @default.
• W3129477788 hasConceptScore W3129477788C190139176 @default.
• W3129477788 hasConceptScore W3129477788C203014093 @default.
• W3129477788 hasConceptScore W3129477788C2776376669 @default.
• W3129477788 hasConceptScore W3129477788C2777637488 @default.
• W3129477788 hasConceptScore W3129477788C2987404301 @default.
• W3129477788 hasConceptScore W3129477788C501593827 @default.
• W3129477788 hasConceptScore W3129477788C523546767 @default.
• W3129477788 hasConceptScore W3129477788C54355233 @default.
• W3129477788 hasConceptScore W3129477788C61511704 @default.
• W3129477788 hasConceptScore W3129477788C71924100 @default.
• W3129477788 hasConceptScore W3129477788C86803240 @default.
• W3129477788 hasConceptScore W3129477788C89423630 @default.
• W3129477788 hasConceptScore W3129477788C94665300 @default.
• W3129477788 hasIssue "1" @default.
• W3129477788 hasLocation W31294777881 @default.
• W3129477788 hasLocation W31294777882 @default.
• W3129477788 hasOpenAccess W3129477788 @default.
• W3129477788 hasPrimaryLocation W31294777881 @default.
• W3129477788 hasRelatedWork W2094932971 @default.
• W3129477788 hasRelatedWork W2309481956 @default.
• W3129477788 hasRelatedWork W2790286024 @default.
• W3129477788 hasRelatedWork W2887504327 @default.
• W3129477788 hasRelatedWork W3139452833 @default.
• W3129477788 hasRelatedWork W3164542293 @default.
• W3129477788 hasRelatedWork W3205386570 @default.
• W3129477788 hasRelatedWork W4206372169 @default.
• W3129477788 hasRelatedWork W4292552678 @default.
• W3129477788 hasRelatedWork W4306912234 @default.
• W3129477788 hasVolume "21" @default.

• next